During in vitro studies in RNF43 mutant and R-spondin fusion CRC cell lines, Rxc004 could potently repress the cell proliferation by arresting cell cycle at G1/S and G2/M phase (Shah et al., 2021). The gene discussed is RNF43; the disease is colorectal carcinoma.